Terms: = Liver cancer AND CCNE1, CCNE, 898, ENSG00000105173, P24864 AND Staging
6 results:
1. Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma
Xu X; Wang MD; Xu JH; Fan ZQ; Diao YK; Chen Z; Jia HD; Liu FB; Zeng YY; Wang XM; Wu H; Qiu W; Li C; Pawlik TM; Lau WY; Shen F; Lv GY; Yang T
Front Immunol; 2023; 14():1322233. PubMed ID: 38268916
[TBL] [Abstract] [Full Text] [Related]
2. Cytochrome P2E1 (CYP2E1) Gene Polymorphism as a Potential Prognostic Biomarker in Colorectal cancer.
Moghadas A; Karbalaie Niya MH; Zamani F; Moazzami M; Farhang F; Ajdarkosh H; Khoonsari M; Faraji A; Panahi M; Emtiazi N; Safarnezhad Tameshkel F; Nikkhah M
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2239-2244. PubMed ID: 37505752
[TBL] [Abstract] [Full Text] [Related]
3. An evaluation of the association between radiological parameters and survival outcomes in pediatric patients with hepatoblastoma.
Sirichamratsakul K; Kritsaneepaiboon S; Sripornsawan P; Kanjanapradit K; Laochareonsuk W; Sangkhathat S
Pediatr Surg Int; 2022 Nov; 38(11):1591-1600. PubMed ID: 36097077
[TBL] [Abstract] [Full Text] [Related]
4. [Analysis of short-term efficacy of overlapping delta-shaped anastomosis in totally laparoscopic left hemicolectomy for digestive tract reconstruction].
Bao MDL; Ge L; Su H; Luo S; Xu Z; Wang XW; Liu Q; Wang ZX; Zhou XS; Zhou HT
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):433-439. PubMed ID: 34000773
[No Abstract] [Full Text] [Related]
5. Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma.
Joseph NM; Tsokos CG; Umetsu SE; Shain AH; Kelley RK; Onodera C; Bowman S; Talevich E; Ferrell LD; Kakar S; Krings G
J Pathol; 2019 Jun; 248(2):164-178. PubMed ID: 30690729
[TBL] [Abstract] [Full Text] [Related]
6. Identification of the resection severity index as a significant independent prognostic factor for early mortality and observed survival >5 and >10 years after liver resection for hepatocellular carcinoma.
Gwiasda J; Schulte A; Kaltenborn A; Ramackers W; Kleine M; Beetz O; Klempnauer J; Emmanouilidis N; Schrem H
Surg Oncol; 2017 Jun; 26(2):178-187. PubMed ID: 28577724
[TBL] [Abstract] [Full Text] [Related]
